US EditionPublished • loading... • Updated
Fury over decision to axe ‘last hope’ cancer treatment from NHS
Charities argue NICE's removal of Tecartus denies patients with limited options a last hope; median survival in NHS use was 2.5 years versus 4 years in trials.
Summary by The Independent
3 Articles
3 Articles
Charities launch appeal to reverse Nice decision on life-saving cancer treatment
Blood Cancer UK, Lymphoma Action and stem cell charity Anthony Nolan have formally appealed against the decision. A formal appeal has been sent to the NHS spending watchdog regarding its decision to remove a potentially life-saving cancer treatment from the health service in England and Wales. Tecartus – which engineers a patient’s own immune cells to kill cancer – was made available for people with a rare type of non-Hodgkin lymphoma through th…
The IndependentReposted by 
The Independent (US)
The Independent (US)Fury over decision to axe ‘last hope’ cancer treatment from NHS
It’s being called a ‘backward step for NHS care’
·London, United Kingdom
Read Full ArticleCoverage Details
Total News Sources3
Leaning Left3Leaning Right0Center0Last UpdatedBias Distribution100% Left
Bias Distribution
- 100% of the sources lean Left
100% Left
L 100%
Factuality
To view factuality data please Upgrade to Premium
